Stoke Therapeutics (STOK) Earnings Date & Reports

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the bodyâ€™s potential with RNA medicine... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

STOK is expected to report earnings to fall 211.11% to 20 cents per share on May 12

Stoke Therapeutics STOK Stock Earnings Reports

Q1'25

Est.

$0.20

Q4'24

Beat

by $0.37

Q3'24

Beat

by $0.07

Q2'24

Beat

by $0.09

Q1'24

Beat

by $0.05

The last earnings report on March 18 showed earnings per share of -18 cents, beating the estimate of -55 cents. With 383.19K shares outstanding, the current market capitalization sits at 359.08M.

View a ticker or compare two or three

Compare

STOK